Category: News

No stranger to the limelight, being the author of our “Views from the Bench – Chemist’s Blog”, Phil Thorne has been involved with the Scientific Laboratory Show’s new campaign to chronicle the ‘History of the Laboratory in Ten Objects’.

Phil points to the mass-production of laboratory glassware as a major turning point in the history of the laboratory.

phil-thorne

The top ten nominated objects will go into the Show’s ‘Hall of Fame’ on 25th May, and delegates will be asked to vote for their Number One object during the Show and conference.

Further details are available here:

www.scientificlaboratoryshow.com/content/news

Dr Robin Wilkes, Business Development Director

Dr Robin Wilkes, Business Development Director

Our Business Development Director, Robin Wilkes, took a look at positive signs for the Drug Discovery industry earlier this year and assembled some of the reasons behind this in an article he put together for a number of news websites. It is reproduced here:-

Seems like we have only just started 2016 but already there’s positive signs in the news for how the Pharmaceutical industry is now addressing the discovery of new medicines…

1. There were 51 New Drug Approvals in 2015, a 66 year high, with nearly 40% of those being ‘first in class’ therapeutics and 60% being small molecules. Perhaps this shows increasing innovation levels in the industry including……

2. The delivery of new technologies such as 3D-printing, from which the first Drug Approval was granted by the FDA in 2015. Spritam® (levetiracetam), for the treatment of epileptic seizures, is the first drug to be manufactured with this technology. Innovation will be further driven by…

3. The availability of new molecular tools, such as CRISPR-Cas9, which edits genes and from which there are positive hopes for the delivery of new therapeutics. There also appears to have been a refocusing of where resources are deployed, for example….

4. The industry appears to have woken up to the important need for new Antibiotics, with new and fairer ways to pay for their development now on the agendas of both Pharma companies and Governments. And…

5. Pharma companies are now also focusing more on Rare or Orphan diseases, defined as those which affect <200K people in USA or <5 in 10K people in Europe. 2016 will see two drugs enter the market for such diseases that have the potential to become ‘blockbusters’, prompting interest beyond niche Biotech companies.

Charnwood-Molecular-Conferences-Q2-2016

We are in the process of putting together our conference schedule for the next couple of months.

So far we have a couple of events on the horizon:

Event: 27th Symposium on Medicinal Chemistry in Eastern England
Date: 21 April 2016
Venue: Hatfield, UK

Event: Kinase 2016: Next Generation Inhibitors
Date: 16-17 May 2016
Venue: BioCity, Nottingham

Should you wish to meet us at either of these, please email us at: info@charnwood-molecular.com

Frontiers in Med Chem, Bonn

Charnwood Molecular will be exhibiting at Frontiers in Medicinal Chemistry in Bonn next week alongside Reach Separations. We look forward to meeting both existing collaborators and new clients.

Please visit us to pick up several new technical notes that we have available on our range of Synthetic Chemistry services for Drug Discovery programs.

The international symposium will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Target Identification & Lead Discovery, Allosteric Modulators & Modulation of Protein-Protein Interactions, Antibacterial Drugs, Structural Biology, and Highlights in Medicinal Chemistry and Technology. The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research.

If you wish to meet at the event, please get in touch with Dr Sylvain Blanc by email at:
s.blanc@charnwood-molecular.com

Charnwood Molecular - Conferences March 2016

Charnwood Molecular is represented at the forthcoming Mastering MedChem symposium, with Dr David Lathbury speaking at the event.

The BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry takes place on 9 March 2016 in Huddersfield.

In the main there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems. The difference between success and failure is how we, as medicinal chemists, tackle and resolve the problems.

If you would like further information, please email us at : info@charnwood-molecular.com or visit: http://www.rsc.org/events/detail/19080/the-bmcs-mastering-medchem-ii-2nd-rsc-bmcs-symposium-on-mastering-medicinal-chemistry

Charnwood Molecular - Conferences March 2016

We are attending the following events and conferences next month.

If you would like further information on our participation in any of the following events, or would like to arrange to meet one of our representatives at any of the venues, please contact us via email at:

info@charnwood-molecular.com

Event: Mastering MedChem: 2nd RSC-BMCS Symposium
Date: 9 March 2016
Venue: University of Huddersfield

Event: Frontiers in Medicinal Chemistry
Date: 13-16 March 2016
Venue: Bonn, Germany

Event: 5th RSC/SCI Symposium on Ion channels as Therapeutic Targets
Date: 14-15 March 2016
Venue: Wellcome Genome Campus Conference Centre, Cambridge, UK

Event: Research & Innovation 2016
Date: 23 March 2016
Venue: Trent Vineyard, Nottingham

BLOG UPDATES

Over recent weeks, Phil Thorne, our blogger reporting on all things medicinal chemistry has posted on a wide range of topics, from the prevalence of drug fraud through to the zika virus.

To read “Views from the Bench – a Chemist’s Blog” click the image below:

views from the bench masthead

Charnwood Molecular are seeking new recruits to join our growing team.

We are currently recruiting at various levels and invite applications from suitable candidates with backgrounds in the following areas:

• Synthetic Chemistry
• Medicinal Chemistry
• Process Research and Development

More details and information on applying are available here:

www.charwnood-molecular.com/careers/

Charnwood Molecular - Conferences Q1 2016

We have now finalised the conferences that we are attending early 2016.

If you would like further information on our participation in any of the following events, or would like to arrange to meet one of our representatives at any of the venues, please contact us via email at:

info@charnwood-molecular.com

Event: Mastering MedChem: 2nd RSC-BMCS Symposium
Date: 9 March 2016
Venue: University of Huddersfield

Event: Frontiers in Medicinal Chemistry
Date: 13-16 March 2016
Venue: Bonn, Germany

Event: 5th RSC/SCI Symposium on Ion channels as Therapeutic Targets
Date: 14-15 March 2016
Venue: Wellcome Genome Campus Conference Centre, Cambridge, UK

Event: Research & Innovation 2016
Date: 23 March 2016
Venue: Trent Vineyard, Nottingham

Paul @ Biocity

We were recently visited at our BioCity lab by Gemma Toulson, the Business Editor of the Nottingham Post.

Gemma put together a piece on Charnwood Molecular/the BioCity lab which featured in the newspaper a little while ago, but it is now available to view online here:

http://www.nottinghampost.com/Firm-s-formula-success/story-27573860-detail/story.html